YTYingfang Tian

Yingfang Tian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yingfang Tian has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Glen C. Jickling

    Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada

    7 shared publications
  • Dazhi Liu

    Departments of Neurology, and the MIND Institute, University of California at Davis, Sacramento, California USA 95817

    4 shared publications
  • Frank R. Sharp

    Departments of Neurology, and the MIND Institute, University of California at Davis, Sacramento, California USA 95817

    4 shared publications
  • Boryana Stamova

    Departments of Neurology, and the MIND Institute, University of California at Davis, Sacramento, California USA 95817

    3 shared publications
  • Bradley P. Ander

    Departments of Neurology, and the MIND Institute, University of California at Davis, Sacramento, California USA 95817

    3 shared publications
  • Renee Jade Turner

    School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia

    3 shared publications

Latest Publications

  • Y Chromosome Gene Expression in the Blood of Male Patients With Ischemic Stroke Compared With Male Controls

    by Yingfang Tian, Boryana Stamova, Glen C. Jickling, Huichun Xu, Dazhi Liu, Bradley P. Ander, Cheryl Bushnell, Xinhua Zhan, Renee J. Turner, Ryan R. Davis, et al.


  • Effects of Gender on Gene Expression in the Blood of Ischemic Stroke Patients

    by Yingfang Tian, Boryana Stamova, Glen C Jickling, Dazhi Liu, Bradley P Ander, Cheryl Bushnell, Xinhua Zhan, Ryan R Davis, Piero Verro, William C Pevec, et al.

    This study examined the effects of gender on RNA expression after ischemic stroke (IS). RNA obtained from blood of IS patients ( n = 51; 153 samples at ≤ 3, 5, and 24 hours) and from matched controls ( n = 52) were processed on Affymetrix microarrays. Analyses of covariance for stroke versus control samples were performed separately for both genders and the regulated genes for females compared with males. In all, 242, 227, and 338 male-specific genes were regulated at ≤ 3, 5, and 24 hours after IS, respectively, of which 59 were regulated at all time points. Overall, 774, 3,437, and 571 female-specific stroke genes were regulated at ≤ 3, 5, and 24 hours, respectively, of which 152 were regulated at all time points. Male-specific stroke genes were associated with integrin, integrin-liked kinase, actin, tight junction, Wnt/β-catenin, RhoA, fibroblast growth factors (FGF), granzyme, and tumor necrosis factor receptor (TNFR)2 signaling. Female-specific stroke genes were associated with p53, high-mobility group box-1, hypoxia inducible factor (HIF)1α, interleukin (IL)1, IL6, IL12, IL18, acute-phase response, T-helper, macrophage, and estrogen signaling. Cell death signaling was overrepresented in both genders, although the molecules and pathways differed. Gender affects gene expression in the blood of IS patients, which likely implies gender differences in immune, inflammatory, and cell death responses to stroke.


  • Exon expression and alternatively spliced genes in tourette syndrome

    by Yingfang Tian, Isaac H. Liao, Xinhua Zhan, Joan R. Gunther, Bradley P. Ander, Dazhi Liu, Lisa Lit, Glen C. Jickling, Blythe A. Corbett, Netty G.P. Bos‐Veneman, et al.

    Tourette Syndrome (TS) is diagnosed based upon clinical criteria including motor and vocal tics. We hypothesized that differences in exon expression and splicing might be useful for pathophysiology and diagnosis. To demonstrate exon expression and alternatively spliced gene differences in blood of individuals with TS compared to healthy controls (HC), RNA was isolated from the blood of 26 un‐medicated TS subjects and 23 HC. Each sample was run on Affymetrix Human Exon 1.0 ST (HuExon) arrays and on 3′ biased U133 Plus 2.0 (HuU133) arrays. To investigate the differentially expressed exons and transcripts, analyses of covariance (ANCOVA) were performed, controlling for age, gender, and batch. Differential alternative splicing patterns between TS and HC were identified using analyses of variance (ANOVA) models in Partek. Three hundred and seventy‐six exon probe sets were differentially expressed between TS and HC (rawP < 0.005, fold change >|1.2|) that separated TS and HC subjects using hierarchical clustering and Principal Components Analysis. The probe sets predicted TS compared to HC with a >90% sensitivity and specificity using a 10‐fold cross‐validation. Ninety genes (transcripts) had differential expression of a single exon (rawP < 0.005) and were predicted to be alternatively spliced (rawP < 0.05) in TS compared to HC. These preliminary findings might provide insight into the pathophysiology of TS and potentially provide prognostic and diagnostic biomarkers. However, the findings are tempered by the small sample size and multiple comparisons and require confirmation using PCR or deep RNA sequencing and a much larger patient population.


  • Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects

    by Yingfang Tian, Michelle L. Apperson, Bradley P. Ander, Dazhi Liu, Boryana S. Stomova, Glen C. Jickling, Richelle Enriquez, Mark A. Agius, Frank R. Sharp


  • Open Access

    Genome response to tissue plasminogen activator in experimental ischemic stroke

    by Glen C Jickling, Xinhua Zhan, Bradley P Ander, Renée J Turner, Boryana Stamova, Huichun Xu, Yingfang Tian, Dazhi Liu, Ryan R Davis, Paul A Lapchak, et al.

    Tissue plasminogen activator (tPA) is known to have functions beyond fibrinolysis in acute ischemic stroke, such as blood brain barrier disruption. To further delineate tPA functions in the blood, we examined the gene expression profiles induced by tPA in a rat model of ischemic stroke.


  • Open Access

    Correlations of Gene Expression with Blood Lead Levels in Children with Autism Compared to Typically Developing Controls

    by Yingfang Tian, Peter G. Green, Boryana Stamova, Irva Hertz-Picciotto, Isaac N. Pessah, Robin Hansen, Xiaowei Yang, Jeffrey P. Gregg, Paul Ashwood, Glen Jickling, et al.

    The objective of this study was to examine the correlation between gene expression and lead (Pb) levels in blood in children with autism (AU, n = 37) compared to typically developing controls (TD, n = 15). We postulated that, though lead levels did not differ between the groups, AU children might metabolize lead differently compared to TD children. RNA was isolated from blood and processed on Affymetrix microarrays. Separate analyses of covariance (ANCOVA) corrected for age and gender were performed for TD, AU, and all subjects (AU + TD). To reduce false positives, only genes that overlapped these three ANCOVAs were considered. Thus, 48 probe sets correlated with lead levels in both AU and TD subjects and were significantly different between the groups (p(Diagnosis × log2 Pb) < 0.05). These genes were related mainly to immune and inflammatory processes, including MHC Class II family members and CD74. A large number (n = 791) of probe sets correlated (P ≤ 0.05) with lead levels in TD but not in AU subjects; and many probe sets (n = 162) correlated (P ≤ 0.05) with lead levels in AU but not in TD subjects. Only 30 probe sets correlated (P ≤ 0.05) with lead levels in a similar manner in the AU and TD groups. These data show that AU and TD children display different associations between transcript levels and low levels of lead. We postulate that this may relate to the underlying genetic differences between the two groups, though other explanations cannot be excluded.


  • Open Access

    Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood

    by Boryana S Stamova, Michelle Apperson, Wynn L Walker, Yingfang Tian, Huichun Xu, Peter Adamczy, Xinhua Zhan, Da-Zhi Liu, Bradley P Ander, Isaac H Liao, et al.

    Gene expression studies require appropriate normalization methods. One such method uses stably expressed reference genes. Since suitable reference genes appear to be unique for each tissue, we have identified an optimal set of the most stably expressed genes in human blood that can be used for normalization.